Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2026-02-13 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a press release titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Report on Share Buybacks). It details the specific number of shares purchased, the average price, and the total value of the transactions conducted by Svas Biosana S.p.A. under an authorized share buyback program. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2026-02-13 Italian
Ricavi consolidati 2025
Earnings Release Classification · 100% confidence The document is a press release titled 'SVAS COMUNICA I RICAVI CONSOLIDATI PRELIMINARI 2025' (SVAS announces preliminary consolidated revenues for 2025). It provides key financial highlights, such as total revenue figures and growth percentages, and includes commentary from the CEO. It is an initial announcement of financial results rather than a full quarterly or annual report, fitting the definition of an Earnings Release (ER). FY 2025
2026-02-12 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a press release titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Report on Share Buybacks). It details the specific number of shares purchased, the average price, and the total value of the transactions conducted by Svas Biosana S.p.A. under an authorized share buyback program. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2026-02-06 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a press release titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Report on Share Buybacks). It details the specific number of shares purchased, the average price, and the total value of the transactions conducted by Svas Biosana S.p.A. under an authorized share buyback program. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2026-01-30 Italian
Calendario finanziario 2026
Report Publication Announcement Classification · 95% confidence The document is a press release from Svas Biosana S.p.A. announcing its 'Calendario finanziario 2026' (2026 Financial Calendar). It lists the dates for upcoming board meetings, financial reporting, and shareholder meetings. According to the 'Menu vs Meal' rule, this is an announcement regarding the timing of future reports rather than the reports themselves. Therefore, it is classified as a Report Publication Announcement (RPA).
2026-01-30 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a press release titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Report on Share Buybacks). It details the specific number of shares purchased, the average price, and the total value of the transactions over a specific period (January 19-23, 2026). This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2026-01-23 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.